High Incidence of Invasive Aspergillosis Associated with Intestinal Graft-versus-Host Disease following Nonmyeloablative Transplantation

This publication has 36 references indexed in Scilit:

• Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation
  Bone Marrow Transplantation, 2004
• High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma
  Bone Marrow Transplantation, 2003
• Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
  Blood, 2002
• Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
  Bone Marrow Transplantation, 2002
• Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes
  Blood, 2002
• Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
  New England Journal of Medicine, 2002
• A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome
  Bone Marrow Transplantation, 2001
• Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
  Blood, 1998
• Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation
  The Journal of Infectious Diseases, 1997
• Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
  Bone Marrow Transplantation, 1997